Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Dextran
Drug ID BADD_D00635
Description Dextran is a polysaccharide that differs from others in that its glucose units are joined together 1:6 glucoside links. The main chain of glucose has short branches at frequent intervals which are probably joined by 1:3 and 1:4 glucoside links. The chains can be composed of about 200,000 glucose units.[A32011] Many bacteria, like _Leuconostoc_, can synthesize dextran from sucrose, and this activity is used commercially to obtain dextran.[T121] Dextran 40 is a sterile, nonpyrogenic preparation of low molecular weight dextran (average mol. wt. 40,000) in 5% Dextrose Injection or 0.9% Sodium Chloride Injection. It is administered by intravenous infusion. Dextran 75 is a complex branched glucan with an average molecular weight 75000 Daltons. It is produced from certain bacteria that with α-1,6 glycosidic linkages between glucose molecules and α-1,3 linkages between branches. When labelled with technetium Tc99m, dextran 75 is intravenously administered as an imaging agent to detect and diagnose conditions in the vascular compartment such as pericardial effusion or ventricular aneurysm.
Indications and Usage Dextran is used as the restoration of blood mass during surgical interventions if there is hypovolemia due to trauma or dehydration. It is as well used after the presence of hemorrhage in cases of blood loss to a level inferior to 15% of the blood mass, if compatibility test cannot be completed or when blood lots need to be tested for pathogen detection. Dextran is also used for the prevention of profound postoperative venous thrombosis.[L1455] Dextran as well presents ophthalmic applications as solutions or ointments for the temporary relief of xerophthalmia or minor ocular irritations.[L1461]
Marketing Status approved; investigational; vet_approved
ATC Code B05AA05
DrugBank ID DB09255
KEGG ID D00060
MeSH ID D003911
PubChem ID 4125253
TTD Drug ID D00UJF
NDC Product Code 49442-5600; 49442-5800; 49442-5040
UNII 7SA290YK68
Synonyms Dextrans | Dextran Derivatives | Dextran 40000 | Dextran 70 | Dextran M 70 | Dextran 75 | Dextran 80 | Dextran B-1355-S | Dextran B 1355 S | Dextran B1355 | Dextran B-1355 | Dextran B 1355 | Dextran B512 | Dextran T 70 | Dextran T-40 | Dextran T 40 | Dextran T-500 | Dextran T 500 | Hemodex | Hyskon | Infukoll | Macrodex | Polyglucin | Promit | Rheodextran | Rheoisodex | Rheomacrodex | Rheopolyglucin | Rondex | Saviosol | Dextran 40 | Dextran
Chemical Information
Molecular Formula C18H32O16
CAS Registry Number 9004-54-0
SMILES C(C1C(C(C(C(O1)OCC2C(C(C(C(O2)OCC(C(C(C(C=O)O)O)O)O)O)O)O)O)O)O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Anaphylactic shock10.01.07.002; 24.06.02.004--Not Available
Anaphylactoid reaction24.06.03.007; 10.01.07.003--Not Available
Body temperature increased13.15.01.001--Not Available
Cardiac arrest02.03.04.001--
Chest discomfort22.12.02.002; 08.01.08.019; 02.02.02.009--Not Available
Extravasation08.01.03.008--Not Available
Hypervolaemia02.05.04.019; 14.05.06.003--Not Available
Hypotension24.06.03.002--
Infection11.01.08.002--Not Available
Injection site infection12.07.03.008; 11.01.08.005; 08.02.03.019--Not Available
Nausea07.01.07.001--
Phlebitis24.12.03.004; 12.02.01.002--
Pyrexia08.05.02.003--
Shock24.06.02.002--Not Available
Urticaria23.04.02.001; 10.01.06.001--
Venous thrombosis24.01.01.008--Not Available
Vomiting07.01.07.003--
Wheezing22.03.01.009--
The 1th Page    1    Total 1 Pages